Pten Loss Drives Overproduction of Brain Cells
Researchers mapped how losing the Pten gene reroutes glial production in developing brain stem cells.
Updated on Nov. 18, 2026 in Life Sciences

Researchers at the Institute of Science and Technology Austria (ISTA) and collaborators found that individual brain stem cells lacking the Pten gene generated roughly 25% more neurons than normal neighboring cells. The mutant cells also produced substantially more astrocytes, and both cell types grew larger than normal.
Why it matters
Mutations in PTEN are associated with PTEN Hamartoma Tumor Syndrome, which is linked to megalencephaly, autism spectrum disorder, intellectual disability, epilepsy and brain tumors. Understanding how the gene shapes brain cell production at the single-cell level may help explain these associated conditions.
The study used MADM to delete Pten in a sparse fraction of cortical radial glial stem cells while tagging them with fluorescent markers, allowing comparison against normal neighboring cells. Whether the same cell-level changes occur in human brain development remains unaddressed in the findings.
The players
Institute of Science and Technology Austria (ISTA)
A research institute in Klosterneuburg, Austria, focused on basic research across the natural sciences and mathematics, and the institution of the research group behind the study.
Sorbonne Université
A major research university in Paris, France, that collaborated on the study.
Yale School of Medicine
The medical school of Yale University in New Haven, Connecticut, that collaborated on the study.
Vetmeduni Vienna
The University of Veterinary Medicine in Vienna, Austria, that collaborated on the study.
The details
Researchers simultaneously switched off Pten and Egfr in individual radial glial cells and found that the Pten-deficient progenitors bypassed the standard EGFR route to generate astrocytes. Instead, they rerouted glial differentiation through the MAPK pathway, a finding that may point to a future therapeutic target.
Timeline
Study published in Science Advances on November 16, 2026.
The Big Picture
The study uses the MADM mosaic genetic technique to examine individual radial glial stem cells rather than whole-tissue populations, extending its use to a disease-linked gene. This single-cell resolution contrasts with earlier whole-brain Pten deletion studies, which produced severe early lethality in animal models.
The findings are preliminary and come from animal models, so no change to clinical care follows directly. The research may eventually inform how clinicians understand the neurological features associated with PTEN mutations.
The takeaway
Single-cell studies can reveal gene effects that whole-tissue experiments obscure, which matters for understanding how mutations lead to brain disorders. Readers interested in the underlying biology can follow how developmental genes guide cell fate in the brain.
Further reading
Explore more Life Sciences coverage on how individual cells shape tissue development.



